|
Market Closed -
Bombay S.E.
06:02:33 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 2,404.80 INR | -1.23% |
|
-4.68% | -2.68% |
| 08-03 | GSK India first-quarter profit rises on steady vaccine demand | RE |
| 08-03 | GlaxoSmithKline Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 | CI |
| Market Cap | 407B 4.29B 3.83B 3.54B 3.21B 6.01B 6.1B 42.59B 16.85B 213B 16.1B 15.76B 673B | P/E 2027 * |
35x | P/E 2028 * | 30.4x |
|---|---|---|---|---|---|
| Enterprise Value | 407B 4.29B 3.83B 3.54B 3.21B 6.01B 6.1B 42.59B 16.85B 213B 16.1B 15.76B 673B | EV / Sales 2027 * |
9.57x | EV / Sales 2028 * | 8.62x |
| Free-Float |
24.37% | Yield 2027 * |
1.23% | Yield 2028 * | 1.23% |
| Markets | Quality | ||
|---|---|---|---|
Bombay S.E.
| GLAXO | Delayed | |
NSE India S.E.
| GLAXO | Delayed |
Last Transcript: GlaxoSmithKline Pharmaceuticals Limited
| 1 day | -1.23% | ||
| 1 week | -4.68% | ||
| Current month | -13.11% | ||
| 1 month | -16.25% | ||
| 3 months | -5.73% | ||
| 6 months | -2.35% | ||
| Current year | -2.68% |
| 1 week | 2,342.7 |  | 2,575 |
| 1 month | 2,342.7 | | 2,986.65 |
| Current year | 2,088 | | 3,121.1 |
| 1 year | 2,088 | | 3,121.1 |
| 3 years | 1,387.9 | | 3,515.95 |
| 5 years | 1,228 | | 3,515.95 |
| 10 years | 1,020 | | 3,515.95 |
| Manager | Title | Age | Since |
|---|---|---|---|
Bhushan Akshikar
CEO | Chief Executive Officer | 56 | 2022-11-30 |
Ronojit Biswas
DFI | Director of Finance/CFO | - | 2026-03-31 |
Shalini Menon
CTO | Chief Tech/Sci/R&D Officer | - | 2024-07-07 |
| Director | Title | Age | Since |
|---|---|---|---|
Renu Sud Karnad
CHM | Chairman | 73 | 2019-03-31 |
| Director/Board Member | 59 | 2020-05-17 | |
Manu Anand
BRD | Director/Board Member | 67 | 2022-05-15 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.23% | -4.68% | -12.93% | +57.58% | 4.35B | |
| -2.54% | +1.75% | +56.75% | +117.82% | 1,165B | |
| -1.42% | +4.16% | +36.73% | +72.42% | 645B | |
| +0.16% | +0.79% | +24.91% | +95.34% | 504B | |
| -0.31% | +2.95% | +39.36% | +63.56% | 380B | |
| -1.34% | +0.06% | +65.81% | +41.49% | 363B | |
| -0.68% | +1.67% | +22.07% | +50.94% | 297B | |
| -1.20% | +0.99% | +2.26% | +22.95% | 269B | |
| -1.79% | +1.20% | +48.41% | +57.55% | 237B | |
| -0.73% | -0.85% | +28.47% | +100.57% | 195B | |
| Average | -0.70% | +1.94% | +31.18% | +68.02% | 405.98B | |
| Weighted average by Cap. | -0.20% | +3.16% | +40.73% | +80.31% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 42.57B 448M 400M 370M 335M 628M 638M 4.45B 1.76B 22.28B 1.68B 1.65B 70.35B | 47.24B 498M 444M 410M 372M 697M 708M 4.94B 1.95B 24.73B 1.87B 1.83B 78.07B |
| Net income | 11.65B 123M 110M 101M 91.81M 172M 175M 1.22B 482M 6.1B 461M 451M 19.26B | 13.42B 141M 126M 116M 106M 198M 201M 1.4B 555M 7.02B 530M 519M 22.18B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-23 | ₹2,404.80 | -1.23% | 3,432 |
| 26-10-22 | ₹2,434.70 | -1.18% | 1,430 |
| 26-10-21 | ₹2,463.75 | -1.04% | 2,472 |
| 26-10-19 | ₹2,489.70 | -2.94% | 1,124 |
| 26-10-16 | ₹2,565.20 | +1.67% | 2,374 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLAXO Stock
Select your edition
All financial news and data tailored to specific country editions
